Amber Beth Blesedell, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 104 Mascuppic Trl, Tyngsboro, MA 01879 Phone: 802-598-9447 |
News Archive
Isansys Lifecare, a new generation digital healthcare company from Oxford, has fought off competition from across the country to be nominated for a prestigious national innovation award which will see the company heading to Parliament later this month.
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
Researchers at Wake Forest University Baptist Medical Center have identified a second promising treatment target for glioblastoma multiforme, one of the most deadly types of brain tumors. The research results are reported in the October issue of Molecular Cancer Research.
Forest Laboratories, Inc. announced today that the U.S. Food and Drug Administration did not approve the additional indication for Bystolic® (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company's Supplemental New Drug Application (sNDA).
› Verified 9 days ago